Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2509-4254
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument ; volume:6 ; number:4 ; day:2 ; month:6 ; year:2022 ; pages:563-574 ; date:7.2022
PharmacoEconomics - open ; 6, Heft 4 (2.6.2022), 563-574, 7.2022
- Urheber
-
Reaney, Matthew
Allen, Veleka
Sehnert, Amy J.
Fang, Liang
Hagège, Albert A.
Naidu, Srihari S.
Olivotto, Iacopo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-022-00335-5
- URN
-
urn:nbn:de:101:1-2022091619535320657966
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Reaney, Matthew
- Allen, Veleka
- Sehnert, Amy J.
- Fang, Liang
- Hagège, Albert A.
- Naidu, Srihari S.
- Olivotto, Iacopo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire
Hypertrophic Cardiomyopathy with a Twist
Instrument completion and validation of the patient-reported apnea questionnaire (PRAQ)
The development of a patient-reported outcome measure for patients with obstructive sleep apnea: the Patient-Reported Apnea Questionnaire (PRAQ)
Diagnosis and management of hypertrophic cardiomyopathy
Patient Perception of Prolapse Condition Questionnaire: A Validated Patient-Reported Outcome Measure
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy
FHL2 expression and variants in hypertrophic cardiomyopathy
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire
Hypertrophic Cardiomyopathy with a Twist
Instrument completion and validation of the patient-reported apnea questionnaire (PRAQ)
The development of a patient-reported outcome measure for patients with obstructive sleep apnea: the Patient-Reported Apnea Questionnaire (PRAQ)
Diagnosis and management of hypertrophic cardiomyopathy
Patient Perception of Prolapse Condition Questionnaire: A Validated Patient-Reported Outcome Measure
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy
FHL2 expression and variants in hypertrophic cardiomyopathy
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire
Hypertrophic Cardiomyopathy with a Twist
Instrument completion and validation of the patient-reported apnea questionnaire (PRAQ)
The development of a patient-reported outcome measure for patients with obstructive sleep apnea: the Patient-Reported Apnea Questionnaire (PRAQ)
Diagnosis and management of hypertrophic cardiomyopathy
Patient Perception of Prolapse Condition Questionnaire: A Validated Patient-Reported Outcome Measure
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy